BARBARA STANLEY: Open Payments
NPI 1265691265 · FELTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 34 payments from 9 companies in 2025. Trend: 2023 $101 · 2024 $636 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $287 |
| Otsuka America Pharmaceutical, Inc. | 5 | $283 |
| Alkermes, Inc. | 5 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $90 |
| ABBVIE INC. | 4 | $88 |
| Lundbeck LLC | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Tris Pharma Inc | 1 | $15 |
Products named: REXULTI, Auvelity, LYBALVI, CAPLYTA, VRAYLAR, HETLIOZ, COBENFY, Dyanavel XR.
Industry payments across DE — which companies pay providers there.
